Residential proximity to environmental sources of persistent organic pollutants and first-time hospitalizations for myocardial infarction with comorbid diabetes mellitus: A 12-year population-based study

International Journal of Occupational Medicine and Environmental Health

Volumn 23, Issue 1, 2010, Pages 5-13

  Sergeev, Alexander V ^a   Carpenter, David O ^b  

^a OHIO UNIVERSITY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cardiovascular disease; Diabetes Mellitus; Myocardial infarction; Persistent organic pollutants

Indexed keywords

ORGANIC COMPOUND;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; POLLUTANT; RACE; SEX RATIO; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANIC CHEMICALS; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION;

EID: 77952017510     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10001-010-0010-y     Document Type: Article

References (47)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Measuring the Global Burden of Disease and Risk Factors, 1990-2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. New York: The World Bank and Oxford University Press; 2006. p. 1-13.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart Disease and Stroke Statistics - 2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-486
3. Donnan PT, Boyle DI, Broomhall J, Hunter K, MacDonald TM, Newton RW, et al. Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study. Diabet Med 2002;19:448-455
4. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003;290:898-904.
5. Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care 1998;7:240-244
6. Prüss-Üstün A, Corvalán C. Preventing disease through healthy environments: towards an estimate of the environmental burden of disease. Geneva: World Health Organization; 2006.
7. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic pollutants and self-reported cardiovascular disease prevalence: results from the National Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007;115:1204-1209
8. Kang HK, Dalager NA, Needham LL, Patterson DG Jr., Lees PS, Yates K, et al. Health status of Army Chemical Corps Vietnam veterans who sprayed defoliant in Vietnam. Am J Ind Med 2006;49:875-884
9. Kim JS, Lim HS, Cho SI, Cheong HK, Lim MK. Impact of Agent Orange exposure among Korean Vietnam veterans. Ind Health 2003;41:149-157
10. Arsenescu V, Arsenescu RI, King V, Swanson H, Cassis LA. Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environ Health Perspect 2008;116:761-768
11. Dalton TP, Kerzee JK, Wang B, Miller M, Dieter MZ, Lorenz JN, et al. Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc Toxicol 2001;1: 285-298
12. Sergeev AV, Carpenter DO. Hospitalization rates for coronary heart disease in relation to residence near areas contaminated with persistent organic pollutants and other pollutants. Environ Health Perspect 2005;113:756-761
13. Shcherbatykh I, Huang X, Lessner L, Carpenter DO. Hazardous waste sites and stroke in New York State. Environ Health 2005;4:18.
14. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006;29:1638-1644
15. Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 2002;110:853-858
16. Fujiyoshi PT, Michalek JE, Matsumura F. Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air Force veterans of the Vietnam war. Environ Health Perspect 2006;114:1677-1683
17. Codru N, Schymura MJ, Negoita S, Rej R, Carpenter DO. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007;115:1442-1447
18. Kouznetsova M, Huang X, Ma J, Lessner L, Carpenter DO. Increased rate of hospitalization for diabetes and residential proximity of hazardous waste sites. Environ Health Perspect 2007;115:75-79
19. Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr., Mainous AG 3rd. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 2007;103:413-418
20. Huang X, Lessner L, Carpenter DO. Exposure to persistent organic pollutants and hypertensive disease. Environ Res 2006;102:101-106
21. Carpenter DO, Shen Y, Nguyen T, Le L, Lininger LL. Incidence of endocrine disease among residents of New York areas of concern. Environ Health Perspect 2001;109 Suppl 6:845-851
22. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-378
23. Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: The Public Health Disparities Geocoding Project. Am J Public Health 2005;95:312-323
24. Mastin JP. Environmental cardiovascular disease. Cardiovasc Toxicol 2005;5:91-94
25. Boyd DR, Genuis SJ. The environmental burden of disease in Canada: respiratory disease, cardiovascular disease, cancer, and congenital affliction. Environ Res 2008;106:240-249
26. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, et al. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide- producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol 1995;142:1165-1175
27. Gustavsson P, Hogstedt C. A cohort study of Swedish capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Am J Ind Med 1997;32:234-239
28. Lakshman MR, Ghosh P, Chirtel SJ. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat. J Pharmacol Exp Ther 1991;258: 317-319
29. Matsusue K, Ishii Y, Ariyoshi N, Oguri K. A highly toxic PCB produces unusual changes in the fatty acid composition of rat liver. Toxicol Lett 1997;91:99-104.
30. Calvert GM, Willie KK, Sweeney MH, Fingerhut MA, Halperin WE. Evaluation of serum lipid concentrations among U.S. workers exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin. Arch Environ Health 1996;51:100-107
31. Goncharov A, Haase RF, Santiago-Rivera A, Morse G, Mc- Caffrey RJ, Rej R, et al. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res 2008;106:226-239
32. Pelclova D, Fenclova Z, Preiss J, Prochazka B, Spacil J, Dubska Z, et al. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8-tetrachlordibenzo-p-dioxin. Int Arch Occup Environ Health 2002;75 Suppl:S60-6.
33. Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE, et al. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 2002;181:174-183
34. Toborek M, Barger SW, Mattson MP, Espandiari P, Robertson LW, Hennig B. Exposure to polychlorinated biphenyls causes endothelial cell dysfunction. J Biochem Toxicol 1995;10:219-226
35. Pelclova D, Prazny M, Skrha J, Fenclova Z, Kalousova M, Urban P, et al. 2,3,7,8-TCDD exposure, endothelial dysfunction and impaired microvascular reactivity. Hum Exp Toxicol 2007;26:705-713
36. Vogel CF, Sciullo E, Matsumura F. Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation. Cardiovasc Toxicol 2004;4:363-373
37. Ferdinand KC. Coronary heart disease and lipid-modifying treatment in African American patients. Am Heart J 2004;147:774-782
38. Bhalotra S, Ruwe MB, Strickler GK, Ryan AM, Hurley CL. Disparities in utilization of coronary artery disease treatment by gender, race, and ethnicity: opportunities for prevention. J Natl Black Nurses Assoc 2007;18:36-49.
39. Rogers RG, Hummer RA, Nam CB. Living and dying in the USA: behavioral, health, and social differentials of adult mortality. San Diego: Academic Press; 2000.
40. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in medicare managed care. JAMA 2002;287:1288-1294
41. Evans GW, Kantrowitz E. Socioeconomic status and health: the potential role of environmental risk exposure. Annu Rev Public Health 2002;23:303-331
42. Faber DR, Krieg EJ. Unequal exposure to ecological hazards: environmental injustices in the Commonwealth of Massachusetts. Environ Health Perspect 2002;110 Suppl 2:277-288
43. Aschengrau A, Seage GR. Essentials of Epidemiology in Public Health. 2nd ed. Sudbury, MA: Jones and Bartlett; 2008.
44. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
45. Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem 2007;18:75-85.
46. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health 1982;72:1336-1344
47. Carpenter DO. Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 2008;23: 59-74.